On October 9th, Gelonhui: Enwei Pharmaceuticals (301331.SZ) announced that as of September 30, 2024, the company has repurchased a total of 3,113,313 shares through a repurchase dedicated securities account in a centralized auction trading manner, accounting for 3.0258% of the total number of company shares (calculated based on the total share capital of the company as of September 30, 2024 of 102,891,887 shares), with the highest fill price at 44.78 yuan per share, the lowest fill price at 21.31 yuan per share, and a total transaction amount of 101,713,739.41 yuan (excluding transaction costs).
恩威医药(301331.SZ)：累计已回购3.03%股份
Enwei Pharmaceutical (301331.SZ): has repurchased 3.03% of the shares accumulated.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha